Greenlight Capital Q2 letter has just been sent to investors, a copy of which was reviewed by ValueWalk. Below is the full letter, check back soon for further coverage any analysis.
The Greenlight Capital funds (the “Partnerships”) returned 7.9%,1 net of fees and expenses, in the second quarter of 2014, bringing the year to date net return to 6.4%. During the second quarter, the S&P 500 index returned 5.2%, bringing the index year-todate return to 7.1%.
Greenlight Capital’s long portfolio contribution
Our long portfolio contributed 14% to our gross return, a strong absolute and relative performance. We made large gains in:
Micron Technology, Inc. (NASDAQ:MU) ($23.66 to $32.95): The spike in DRAM prices from last year turned out not to be a blip and earnings continued to exceed expectations. We believe consensus earnings estimates remain too low, positioning the company for further earnings surprises and multiple expansion.
Apple Inc. (NASDAQ:AAPL) ($76.68 to $92.93): Investors’ 2013 fears that AAPL had saturated the market and its best days were behind it proved unfounded as 130 million people became first-time iOS customers in the last year. Last quarter, AAPL’s EPS grew 15% and the forecast is for more of the same. Importantly, AAPL also increased its share repurchase authorization by $30 billion to $90 billion. Concurrently, AAPL also announced a seven for one stock split. AAPL remains inexpensive at about 11x earnings net of cash.
Greenlight Capital also gains in SUNE, ATC and OIS
We also made significant gains in:
Sunedison Inc (NYSE:SUNE) ($18.84 to $22.60): In May, SUNE completed the IPO of its semiconductor division. SUNE’s yieldco, TerraForm Power (TERP), completed its IPO in July. SUNE completed several solar portfolio acquisitions and disclosed an attractive incentive distribution rights structure that should allow it to enjoy additional value from TERP over time.
Altice SA (AMS:ATC) (€32.34 to €50.88): As we discussed in our last letter, ATC’s 40% owned subsidiary Numericable will buy French competitor SFR to form the second largest telecommunications company in a consolidating market; it also announced its intention to cut more costs and the ability to finance the acquisition at a lower cost than anticipated.
Resona Holdings Inc (TYO:8308) (¥499 to ¥590): Earnings came in slightly above expectations and capital ratios improved materially due to the transition to international accounting standards. This supports the bank’s announced plan to repurchase the government’s equity stake.
Oil States International, Inc. (NYSE:OIS) ($98.60 to $114.15) / Civeo Corp (NYSE:CVEO): OIS completed the spinoff of its legacy accommodations segment, now called Civeo (CVEO). The combined OIS/CVEO share price appreciated as investors re-rated the two businesses closer to their respective fair values. The shares ended the quarter at $114.15 on an old OIS-equivalent basis.
The short portfolio lost a bit less than the market despite a rash of takeover activity that infected a number of positions. Costly takeovers of our shorts appear to be a cyclical phenomenon: We went from 1996-2003 without incurring a single material loss due to a takeover. Then in 2006-2007 we had a number of our shorts taken over in rapid succession, the most costly being Medtronic’s $4.2 billion acquisition of Kyphon at a 32% premium over Kyphon’s already lofty share price. In reviewing historical takeovers of our shorts where we lost money, almost none proved to be good deals for the acquirers.
Things got quieter again for a few years but now takeover season has returned and is again causing losses in our short portfolio. Companies we are short often have serious problems of which the boards and management are probably aware. This makes them more eager than usual to sell at any sort of premium. The prospective buyers ought to discover these problems during due diligence, which should make them walk away. But in the current environment, debt financing is so inexpensive that acquirers can pay premiums and have the deals be accretive to EPS, making them more willing to overlook or ignore any problems they discover.
Takeover season has returned and in a new twist, the buyers’ stock prices are also advancing in response to announced deals, enabling companies, including some of our shorts, to see gains as acquirers – even of other troubled companies. Here are a number of examples that have affected us:
Safeway (SWY) is a deteriorating supermarket chain. In 2008, SWY completed a large remodeling program that failed to adequately lift sales and profits, leaving SWY competitively stuck between Whole Foods on the high end and Walmart on the low end. SWY’s revenues and profits are in decline and SWY has no apparent means of reversing those trends. SWY also has a large off-balance sheet liability to multiemployer pension plans or MEPPs. The disclosure around the MEPPs is hard to analyze, but we have done a thorough job and believe it is approximately an $8 billion unrecognized liability. Though SWY claims that our figures are too high, we have discussed our analysis with management and still believe we are correct. Nonetheless, Albertsons has agreed to purchase SWY for about $10 billion or 17x SWY’s deteriorating EBIT. We don’t know how Albertsons views the MEPP issue.
Martin Marietta Materials (MLM) produces aggregates for the construction industry. The company has missed analyst estimates in 17 of the last 26 quarters, which has led to continuous erosion of earnings estimates. From 2009 to 2013, the company earned between $2.03 and $2.61 per share annually, excluding one-time expenses. Once upon a time, MLM was expected to earn $8 per share this year. Current estimates stand around $3.75. In January, MLM agreed to acquire cement, aggregates and concrete maker, Texas Industries (TXI) for $2.7 billion. TXI appears to be an even worse business, with negative EBIT each year from FY 2010 through FY 2013. However, MLM issued a proxy statement presenting a management forecast (prayer?) that implies post-merger EPS of $12+ in 2018. The market chose to ignore MLM’s long history of missing its forecasts, and its shares advanced more than 20% since January when it announced the acquisition.
Lorillard (LO) makes cigarettes. Over 80% of its profits come from menthol-flavored cigarettes, which were banned in Europe earlier this year. The FDA is six years into evaluating whether to regulate menthol flavoring, and may decide to ban it here, as well. The FDA is due to announce its findings any day now or, perhaps, any year now. This risk did not stop Reynolds American (RAI) from agreeing to acquire LO for $68 per share – a sizable premium to the $48 that LO traded at in February before word of the deal leaked. We suspect that RAI is willing to accept the menthol risk on the theory that in for a penny, in for a pound.
Questcor Pharmaceuticals (QCOR) makes one product, H.P. Acthar Gel, an off-patent drug approved in 1952 for 19 different diseases only two of which have clinical studies demonstrating safety and efficacy. The laundry list of problems and risks that this company faces could fill a lengthy PowerPoint presentation. We won’t review